Key result
Editorial reviews stellate ganglion blockade for ventricular arrhythmia storm management without quantitative findings.
Answers are grounded in this paper and cite their sources.
Supports SGB as temporizing option in refractory VA storm; leaves open need for randomized trials to confirm efficacy and guide adoption.
Journal Article Stellate ganglion blockade for the management of ventricular arrhythmia storm Get access Varun Malik, Varun Malik Cardiac Arrhythmia Center, University of California, Los Angeles (UCLA), 100 UCLA Medical Plaza, Suite 660, Los Angeles, CA 90095, USACentre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia Corresponding author. Tel: +1 310 206 6433, Fax: +1 310 825 2092, Email: VMalik@mednet.ucla.edu https://orcid.org/0000-0002-1564-439X Search for other works by this author on: Oxford Academic PubMed Google Scholar Kalyanam Shivkumar Kalyanam Shivkumar Cardiac Arrhythmia Center, University of California, Los Angeles (UCLA), 100 UCLA Medical Plaza, Suite 660, Los Angeles, CA 90095, USA https://orcid.org/0000-0002-4121-1766 Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 45, Issue 10, 7 March 2024, Pages 834–836, https://doi.org/10.1093/eurheartj/ehae083 Published: 15 February 2024
No takes yet. Share an insight, caveat, or question.
Malik et al. (2024) conducted an editorial in ventricular arrhythmia storm. Stellate ganglion blockade was evaluated. No abstract text is available to provide quantitative findings on stellate ganglion blockade for the management of ventricular arrhythmia storm.
Synapse has enriched 10 related papers. Consider them for comparative context: